EUVIMEDEUVIMED entdecken
Multizentrische StudieVergleichsstudieOpen Access · CC BY-NC 4.0

Liver regeneration after portal and hepatic vein embolization improves overall survival compared with portal vein embolization alone: mid-term survival analysis of the multicentre DRAGON 0 cohort

Remon Korenblik iD, Jan Heil, Jens Smits, Sinead James, Bram Olij, Wolf O Bechstein, Marc H A Bemelmans, Christoph A Binkert, Stefan Breitenstein, Michael Williams, Olivier Detry iD, Maxime J L Dewulf und 17 weitere

British Journal of Surgery · 03.04.2024 · 111 (4)

DOI: 10.1093/bjs/znae087 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift British Journal of Surgery, online erschienen am 25.04.2024. Verfasst von Remon Korenblik und 28 weiteren Autor:innen. Beteiligte Einrichtung: GROW-School for Oncology and Reproduction, Maastricht University, Maastricht, the Netherlands. Hauptthemen laut MEDLINE: Portal Vein, Liver Neoplasms, Embolization, Therapeutic, Liver Regeneration. Die Arbeit wurde bisher 17-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: DRAGON trials.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The purpose of this study was to compare 3-year overall survival after simultaneous portal (PVE) and hepatic vein (HVE) embolization versus PVE alone in patients undergoing liver resection for primary and secondary cancers of the liver.

Methods

In this multicentre retrospective study, all DRAGON 0 centres provided 3-year follow-up data for all patients who had PVE/HVE or PVE, and were included in DRAGON 0 between 2016 and 2019. Kaplan–Meier analysis was undertaken to assess 3-year overall and recurrence/progression-free survival. Factors affecting survival were evaluated using univariable and multivariable Cox regression analyses.

Results

In total, 199 patients were included from 7 centres, of whom 39 underwent PVE/HVE and 160 PVE alone. Groups differed in median age (P = 0.008). As reported previously, PVE/HVE resulted in a significantly higher resection rate than PVE alone (92 versus 68%; P = 0.007). Three-year overall survival was significantly higher in the PVE/HVE group (median survival not reached after 36 months versus 20 months after PVE; P = 0.004). Univariable and multivariable analyses identified PVE/HVE as an independent predictor of survival (univariable HR 0.46, 95% c.i. 0.27 to 0.76; P = 0.003).

Conclusion

Overall survival after PVE/HVE is substantially longer than that after PVE alone in patients with primary and secondary liver tumours.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Portal VeinLiver NeoplasmsEmbolization, TherapeuticLiver RegenerationHepatic VeinsHepatectomyHumansMaleFemaleRetrospective StudiesMiddle AgedAgedSurvival RateSurvival AnalysisAdult

Autor:innen und Institutionen

  • GROW-School for Oncology and Reproduction, Maastricht University, Maastricht, the Netherlands.
  • Department of Surgery, Maastricht University Medical Centre, Maastricht, the Netherlands.
  • Institute of Physiology, University of Zurich, Zurich, Switzerland.
  • Department of General, Visceral and Transplant Surgery, University Hospital Frankfurt, Goethe-University Frankfurt, Frankfurt, Germany.
  • Department of General, Visceral and Transplant Surgery, University Hospital Aachen, Aachen, Germany.
  • Department of Radiology, Cantonal Hospital Winterthur, Winterthur, Switzerland.

ORCID-Profile: Remon Korenblik, Olivier Detry, Lukasz F Grochola, Ronald M van Dam

Förderung

  • DRAGON trials

Zitieren

APA

Korenblik, R., Heil, J., Smits, J., James, S., Olij, B., Bechstein, W. O., Bemelmans, M. H. A., Binkert, C. A., Breitenstein, S., Williams, M., Detry, O., Dewulf, M. J. L., Dili, A., Grochola, L. F., Grote, J., Heise, D., Kalil, J. A., Metrakos, P., Neumann, U. P., …, & DRAGON trials collaborative (2024). Liver regeneration after portal and hepatic vein embolization improves overall survival compared with portal vein embolization alone: mid-term survival analysis of the multicentre DRAGON 0 cohort. British Journal of Surgery, 111(4). https://doi.org/10.1093/bjs/znae087

Vancouver

Korenblik R, Heil J, Smits J, James S, Olij B, Bechstein WO, et al. Liver regeneration after portal and hepatic vein embolization improves overall survival compared with portal vein embolization alone: mid-term survival analysis of the multicentre DRAGON 0 cohort. British Journal of Surgery. 2024;111(4). doi:10.1093/bjs/znae087

BibTeX
@article{Korenblik2024,
  author = {Korenblik, Remon and Heil, Jan and Smits, Jens and James, Sinead and Olij, Bram and Bechstein, Wolf O and Bemelmans, Marc H A and Binkert, Christoph A and Breitenstein, Stefan and Williams, Michael and Detry, Olivier and Dewulf, Maxime J L and Dili, Alexandra and Grochola, Lukasz F and Grote, Jon and Heise, Daniel and Kalil, Jennifer A and Metrakos, Peter and Neumann, Ulf P and Pappas, Sam G and Pennetta, Francesca and Schnitzbauer, Andreas A and Tasse, Jordan C and Winkens, Bjorn and Olde Damink, Steven W M and van der Leij, Christiaan and Schadde, Erik and van Dam, Ronald M and DRAGON trials collaborative, DRAGON trials collaborative},
  title = {Liver regeneration after portal and hepatic vein embolization improves overall survival compared with portal vein embolization alone: mid-term survival analysis of the multicentre DRAGON 0 cohort},
  journal = {British Journal of Surgery},
  year = {2024},
  volume = {111},
  number = {4},
  doi = {10.1093/bjs/znae087}
}
Kostenlos starten →